United States

Atcor Medical Holdings Ltd (ACG.AX)

ACG.AX on Australia Stock Exchange

20 Oct 2017
Change (% chg)

$-0.00 (-3.70%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


AtCor Medical Holdings Ltd is engaged in the designing, manufacturing and marketing of medical devices for use in cardiovascular management. The Company operates through three segments: Americas, which includes global pharmaceutical trials business; Europe, which includes Middle East and Africa, and Asia Pacific, which includes... (more)
No analyst recommendations are available for .


Beta: 1.53
Market Cap(Mil.): $7.31
Shares Outstanding(Mil.): 281.02
Dividend: --
Yield (%): --


  Industry Sector
P/E (TTM): -- 163.65 16.52
EPS (TTM): -- -- --
ROI: -- 9.60 11.32
ROE: -- 14.98 15.18

BRIEF-Atcor Medical Holdings posts FY loss for year of $4.4 mln

* FY revenue from ordinary activities down 14% to $4.3 million

Aug 31 2017

BRIEF-Atcor Medical Holdings seeks trading halt

* Seeks trading halt pending an announcement to market in relation to a potential capital raising Source text for Eikon: Further company coverage:

Aug 03 2017

BRIEF-Atcor Medical updates on management changes

* at appropriate point, board will appoint a new ceo for company based in Australia.

Aug 02 2017

BRIEF-Atcor Medical signs agreement with New York University​

* Entered into a two year agreement with New York University​

Jul 30 2017

BRIEF-Atcor Medical secures new pharmaceutical trials contracts

* Signed three new contracts to supply Sphygmocor systems and clinical trial support services Source text for Eikon: Further company coverage:

Jul 12 2017

BRIEF-AtCor Medical Holdings signs Healthcare Delivery Network agreement with Nephrology Associates

* Asx Alert-AtCor signs new network health systems agreement-ACG.AX

Jun 06 2017

Earnings vs. Estimates